111 related articles for article (PubMed ID: 12943473)
21. [Genomic revolution of rare disease diagnosis].
Mandel JL
Presse Med; 2012 May; 41 Suppl 1():S26-8. PubMed ID: 22503291
[No Abstract] [Full Text] [Related]
22. DNA diagnostics in the fifty-year retrospect.
Demidov VV
Expert Rev Mol Diagn; 2003 Mar; 3(2):121-4. PubMed ID: 12647990
[No Abstract] [Full Text] [Related]
23. Not for the chicken-hearted.
Nat Biotechnol; 2006 Aug; 24(8):870. PubMed ID: 16900108
[No Abstract] [Full Text] [Related]
24. Any diamonds in the diagnostic coal?
Jacobs T
Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
[No Abstract] [Full Text] [Related]
25. Current trends in molecular diagnostics.
Jain KK
Med Device Technol; 2002 Nov; 13(9):14-8. PubMed ID: 12534152
[TBL] [Abstract][Full Text] [Related]
26. The expanding world of molecular pathology.
Wagner BM
Hum Pathol; 2001 Nov; 32(11):1278-9. PubMed ID: 11727273
[No Abstract] [Full Text] [Related]
27. Aspects of molecular diagnostics and therapy in obstetrics and gynecology.
Beckmann MW; Strick R; Strissel PL; Fasching PA; Oppelt P; Pöhls UD; Malur SU; Ackermann S
Expert Rev Mol Diagn; 2003 May; 3(3):279-87. PubMed ID: 12779004
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in biomarkers for cancer diagnosis and treatment.
Manne U; Srivastava RG; Srivastava S
Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
[TBL] [Abstract][Full Text] [Related]
29. Molecular diagnostic testing presents $5 billion conundrum.
Rizk E
Manag Care; 2009 Apr; 18(4):22, 24-5. PubMed ID: 19472563
[No Abstract] [Full Text] [Related]
30. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
31. [Advances in biotechnologies for molecular diagnostics].
Miyachi H
Nihon Rinsho; 2005 Dec; 63 Suppl 12():129-33. PubMed ID: 16416782
[No Abstract] [Full Text] [Related]
32. Molecular diagnostics in routine practice.
Ramsden S
Ann Clin Biochem; 2004 Mar; 41(Pt 2):170-1; author reply 171. PubMed ID: 15025813
[No Abstract] [Full Text] [Related]
33. [Molecular diagnostics of infectious diseases].
Ohkusu K; Ezaki T
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():199-207. PubMed ID: 17455617
[No Abstract] [Full Text] [Related]
34. Do companion diagnostics make economic sense for drug developers?
Agarwal A
N Biotechnol; 2012 Sep; 29(6):695-708. PubMed ID: 22575210
[TBL] [Abstract][Full Text] [Related]
35. [Opportunity and challenge of diagnostic pathology in China].
Liu TH
Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):466-7. PubMed ID: 16383286
[No Abstract] [Full Text] [Related]
36. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
Baudhuin LM; Donato LJ; Uphoff TS
Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
[TBL] [Abstract][Full Text] [Related]
37. Present and future of rapid and/or high-throughput methods for nucleic acid testing.
Csako G
Clin Chim Acta; 2006 Jan; 363(1-2):6-31. PubMed ID: 16102738
[TBL] [Abstract][Full Text] [Related]
38. Tuberculosis diagnostics: test developers' FAQs.
Pai M
Int J Tuberc Lung Dis; 2013 May; 17(5):570-1. PubMed ID: 23575319
[No Abstract] [Full Text] [Related]
39. Towards a reconciliation between molecular diagnostics and new pharmaceuticals.
Gold B
Drug Discov Today; 2002 Oct; 7(20):1034-5. PubMed ID: 12546889
[No Abstract] [Full Text] [Related]
40. Point-of-care diagnostics: will the hurdles be overcome this time?
Huckle D
Expert Rev Med Devices; 2006 Jul; 3(4):421-6. PubMed ID: 16866639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
